Cardiovascular Diseases

The site is conducting research on cardiovascular disease to test new treatments that lower risk of heart events and improve cardiac function.

  • Established cardiovascular disease
  • High cardiovascular risk
  • Hypertension
  • Heart failure
  • Combination therapy with empagliflozin for heart failure

Across the program, 28 trials involve 12 investigators at Lukmed 2 Sp. z o.o., Siedlce, reflecting a strong focus on heart health.

Eye Diseases

Studies target eye diseases by evaluating innovative therapies intended to preserve vision and reduce ocular inflammation.

  • Novel topical agents for ocular inflammation
  • Safety assessment of long‑term eye treatments
  • Improving visual outcomes in retinal disorders

The ophthalmology portfolio contributes to the overall trial count, supporting the hospital’s multidisciplinary approach.

Female Urogenital Diseases and Pregnancy Complications

Research explores endometriosis‑related pain and other female reproductive conditions, aiming to provide better symptom relief and fertility outcomes.

  • Endometriosis‑related chronic pelvic pain
  • Evaluation of new oral agents for uterine health
  • Management strategies for pregnancy‑related complications

These studies complement the site’s broader therapeutic agenda and involve collaboration among gynecologists and pain specialists.

Immune System Diseases

Clinical work investigates immune system diseases, focusing on novel biologics that modulate abnormal immune activity.

  • Primary Sjögren’s syndrome
  • Systemic autoimmune disorders
  • Targeted therapies for immune‑mediated inflammation

The immune‑focused trials are part of the 28 studies run by a team of 12 investigators at the Siedlce hospital.

Musculoskeletal Diseases

The department evaluates treatments for musculoskeletal diseases such as arthritis and chronic back pain, seeking to improve mobility and reduce reliance on opioids.

  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Chronic non‑specific low back pain
  • Biologic biosimilars for joint inflammation

This area benefits from the site’s expertise in rheumatology and pain management, contributing to the overall trial portfolio.

Nervous System Diseases

Ongoing trials address nervous system diseases by testing preventive and therapeutic options for migraine, aiming to decrease attack frequency and severity.

  • Episodic migraine
  • Chronic migraine
  • New injectable therapies for migraine prevention

Neurology research at Lukmed 2 adds depth to the institution’s multi‑disciplinary clinical trial program.

Nutritional and Metabolic Diseases

Investigations target nutritional and metabolic diseases to improve glycemic control and promote weight loss, evaluating both drug and lifestyle‑combined approaches.

  • Type 2 diabetes
  • Obesity and overweight management
  • Weight reduction in patients with metabolic syndrome
  • Adjunctive therapy for diabetes with diet and exercise

These metabolic studies are integrated with the site’s broader effort to address chronic disease burden in the community.

Skin and Connective Tissue Diseases

The hospital conducts trials on skin and connective tissue diseases to assess new topical and systemic agents for conditions like acne and psoriasis.

  • Acne vulgaris
  • Moderate‑to‑severe plaque psoriasis
  • Long‑term safety of novel psoriasis treatments
  • Topical therapy evaluation for acne

Dermatology research complements the other therapeutic programs, contributing to the total of 28 active clinical investigations.